Thoracic perfusion of recombinant mutant human tumor necrosis factor (rmhTNF) can be considered as a good adjunct in the treatment of malignant pleural effusion caused by lung cancer

Peer Review reports

Original Submission
18 Mar 2019	Submitted	Original manuscript
9 Aug 2019	Reviewed	Reviewer Report - Yongchun Shen
3 Dec 2019	Author responded	Author comments - Tian Fu
Resubmission - Version 2
3 Dec 2019	Submitted	Manuscript version 2
3 Jun 2020	Author responded	Author comments - Tian Fu
Resubmission - Version 3
3 Jun 2020	Submitted	Manuscript version 3
Publishing
8 Jun 2020	Editorially accepted
18 Jun 2020	Article published	10.1186/s12890-020-01210-x

Back to article page